Story · Public Health
HLTH 2026: Noom, Hims & Hers expand into booming peptide market
2 outlets · first reported by Fierce Healthcare on · latest · 25 hours of coverage
Noom and Hims & Hers are making a play for the booming peptide market as the federal government loosens restrictions on compounded treatments. (Fierce Healthcare)
Coverage, in order
-
HLTH 2026: Noom, Hims & Hers expand into booming peptide market
Noom and Hims & Hers are making a play for the booming peptide market as the federal government loosens restrictions on compounded treatments.
-
STAT+: Peptide market poised to explode with new Hims and Noom launchesPeptides are poised to go mainstream with this week’s launches from telehealth companies Hims & Hers and Noom, both of which announced they will be offering prescriptions for eligible patients. Synthetic peptides are a broad category of short-chain amino acids. Initially popular among bodybuilders…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.